A D-penicillamin kezelés nem befolyásolja az újszülöttek máj- és vesefunkcióját, valamint in vitro a phagocyták müködését.

Translated title of the contribution: D-penicillamine does not affect the liver and kidney function in newborn infants nor the in vitro function of phagocytes

L. Csáthy, I. Szabó, M. Pataki, L. Lakatos, L. Maródi

Research output: Contribution to journalReview article

1 Citation (Scopus)


D-penicillamine was introduced to treat neonatal hyperbilirubinaemia in 1973 and to prevent retinopathy of prematurity in 1980. In this study we investigated the renal and liver functions of neonates treated with DPA and the in vitro effect of the drug on superoxide anion generation and beta-glucuronidase release as well as on phagocytic and intracellular killing activation on human peripheral blood granulocytes. Our data concerning the renal and liver functions before and after 3 to 4 days DPA treatment reveal no pathological change during short-term administration in the neonatal period. Furthermore, none of the examined DPA concentrations influenced the phagocytic or killing activity of neutrophils.

Original languageHungarian
Pages (from-to)2421-2423
Number of pages3
JournalOrvosi hetilap
Issue number44
Publication statusPublished - Nov 3 1991


ASJC Scopus subject areas

  • Medicine(all)

Cite this